Thomas W. Dubensky

Cerus Corporation

$6,503,384

Attributed

$6,503,384

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.2M · FY2005–14

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$6,503,384 · 5

By mechanism

U01$5,016,844 · 2

R44$1,161,662 · 1

R43$324,878 · 2

Top collaborators

No co-investigators on record.

Most similar at Cerus Corporation

Same institution · by research overlap

Others in their field

Top investigators on “Vaccine Development”

Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
Bambra Strokes · Ppd Development Lp$526,656,217
Barton F Haynes · Duke University$394,383,754
Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
Dennis R. Burton · Scripps Research Institute$312,611,400

Research focus

Vaccine DevelopmentVaccinesImmune ResponsePre-ClinicalToxic EffectToxicologyImmunogenicityImmune SystemLifeNovel TherapeuticsTherapeutic VaccineT-LymphocyteSafetyTreatment EfficacyImmuneCell LineCollaborationsBaseImmunotherapeutic AgentLaboratory MouseListeriaListeria MonocytogenesAttenuatedAutologous Dendritic Cells